CYCLASOL Trademark

Trademark Overview

On Tuesday, January 19, 2016, a trademark application was filed for CYCLASOL with the United States Patent and Trademark Office. The USPTO has given the CYCLASOL trademark a serial number of 86879656. The federal status of this trademark filing is CANCELLED - SECTION 8 as of Friday, May 10, 2024. This trademark is owned by Novaliq GmbH. The CYCLASOL trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for ophthalmic use
cyclasol

General Information

Serial Number86879656
Word MarkCYCLASOL
Filing DateTuesday, January 19, 2016
Status710 - CANCELLED - SECTION 8
Status DateFriday, May 10, 2024
Registration Number5317733
Registration DateTuesday, October 24, 2017
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, June 14, 2016

Trademark Statements

Goods and ServicesPharmaceutical preparations for ophthalmic use

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code2 - Sec. 8 - Entire Registration
Class Status DateFriday, May 10, 2024
Primary Code005
First Use Anywhere DateThursday, October 15, 2015
First Use In Commerce DateThursday, October 15, 2015

Trademark Owner History

Party NameNovaliq GmbH
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressHeidelberg 69120
DE
Party NameNovaliq GmbH
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressHeidelberg 69120
DE
Party NameNovaliq GmbH
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressHeidelberg 69120
DE

Trademark Events

Event DateEvent Description
Wednesday, May 4, 2016ASSIGNED TO EXAMINER
Friday, January 22, 2016NEW APPLICATION ENTERED
Saturday, January 23, 2016NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Wednesday, May 25, 2016NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, June 14, 2016PUBLISHED FOR OPPOSITION
Saturday, February 25, 2017STATEMENT OF USE PROCESSING COMPLETE
Monday, May 9, 2016APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, June 14, 2016OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Thursday, July 21, 2016TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, August 9, 2016NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, February 7, 2017TEAS STATEMENT OF USE RECEIVED
Tuesday, February 7, 2017USE AMENDMENT FILED
Friday, February 24, 2017CASE ASSIGNED TO INTENT TO USE PARALEGAL
Saturday, August 26, 2017ASSIGNED TO LIE
Tuesday, October 24, 2017REGISTERED-PRINCIPAL REGISTER
Monday, October 24, 2022COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Friday, May 10, 2024CANCELLED SEC. 8 (6-YR)
Saturday, September 16, 2017NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Monday, March 13, 2017SU - NON-FINAL ACTION - WRITTEN
Monday, March 13, 2017NON-FINAL ACTION E-MAILED
Monday, March 13, 2017NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, August 7, 2017TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, August 30, 2017CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, August 30, 2017TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, September 15, 2017ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED

Related Keywords

cyclasol ophthalmic preparations pharmaceutical